U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Childhood Acute Myeloid Leukemia

MedGen UID:
82981
•Concept ID:
C0278776
•
Neoplastic Process
Synonyms: Recurrent Childhood Acute Myeloblastic Leukemia; Recurrent Childhood Acute Myelogenous Leukemia; Recurrent Childhood AML; Recurrent Pediatric Acute Myeloblastic Leukemia; Recurrent Pediatric Acute Myelogenous Leukemia; Recurrent Pediatric Acute Myeloid Leukemia; Recurrent Pediatric AML; Relapsed Childhood Acute Myeloblastic Leukemia; Relapsed Childhood Acute Myelogenous Leukemia; Relapsed Childhood Acute Myeloid Leukemia; Relapsed Childhood AML; Relapsed Pediatric Acute Myeloblastic Leukemia; Relapsed Pediatric Acute Myelogenous Leukemia; Relapsed Pediatric Acute Myeloid Leukemia; Relapsed Pediatric AML

Definition

The reemergence of acute myeloid leukemia in childhood after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Childhood Acute Myeloid Leukemia

Professional guidelines

PubMed

Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel.
Abla O, Kutny MA, Testi AM, Feusner JH, Creutzig U, Gregory J Jr, Gibson B, Leverger G, Ribeiro RC, Smith O, Locatelli F, Kaspers G
Br J Haematol 2016 Nov;175(4):588-601. Epub 2016 Sep 21 doi: 10.1111/bjh.14313. PMID: 27651168
Advances in the management of childhood leukemia.
Bowman WP
Tex Med 1985 Mar;81(3):39-44. PMID: 3885465
Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood.
Massimo L, Fossati-Guglielmoni A, Fortuna E
Helv Paediatr Acta 1968 Aug;23(4):315-33. PMID: 4300437

Recent clinical studies

Etiology

Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study.
Steuber CP, Krischer J, Holbrook T, Camitta B, Land V, Sexauer C, Mahoney D, Weinstein H
J Clin Oncol 1996 May;14(5):1521-5. doi: 10.1200/JCO.1996.14.5.1521. PMID: 8622066

Therapy

Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study.
Steuber CP, Krischer J, Holbrook T, Camitta B, Land V, Sexauer C, Mahoney D, Weinstein H
J Clin Oncol 1996 May;14(5):1521-5. doi: 10.1200/JCO.1996.14.5.1521. PMID: 8622066

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...